New whitepaper: Powered by Partnership & Patient Experience
Pharma has long been guilty of putting profit before people, but that's beginning to change. While there's still a long road ahead, patient-engagement efforts are steadily improving.
This is being shared with you as part of the exciting buildup to this year’s Pharma & Patient USA 2025 (Nov 17-18, Philadelphia) conference, where patient champions will gather to incorporate the patient voice at all stages.
The report delves into many important key areas, including:
- Measuring impact and demonstrating value: Pharma are pulling back on funding for advocacy groups due to lack of demonstrable ROI. How can pharma extrapolate the right metrics and measure true ROI in patient engagement?
- Closing the gap on access: What partnerships are required to increase engagement within minority communities, such as the LGBTQIA+ space, to ensure diverse representation in pharma clinical trials?
- Brave new frontiers of technology and patient experience: Generate insights and patterns in patient data to deliver more personalized treatments and improved outcomes.
Provided to you ahead of Pharma & Patient USA 2025, last year speaker line-up included:
We hope you enjoy!
Kindest regards,
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.